BioWorld

July 13, 2005

View Archived Issues

Genentech Tallies Another Quarter Of Strong Earnings

Like a broken record playing a song investors never tire of hearing, Genentech Inc. chalked up another satisfying quarter, with Avastin and Herceptin sales benefiting from a parade of positive news this spring. (BioWorld Today) Read More

Pharmacopeia, Allergan Enter Agreement For Wet AMD Drugs

Read More

From In Vivo Research Come Insights Into P53 Regulation

Read More

Nabi's StaphVAX Phase II Trial Confers Lofty Immunity Levels

Read More

Other News To Note

Read More

Appointments And Advancements

Read More